Avastin No Benefit to Older Lung Cancer Patients: Study – U.S. News & World Report

by lowes1 on April 17, 2012

Avastin No Benefit to Older Lung Cancer Patients: Study
U.S. News & World Report
By Steven Reinberg TUESDAY, April 17 (HealthDay News) — Medicare patients who have advanced non-small cell lung cancer appear to get no survival benefit from adding the drug Avastin to standard chemotherapy, researchers from the Dana-Farber Cancer
Avastin Fails to Help Older Lung-Cancer Patients in StudyBusinessWeek
Adding Drug to Standard Chemotherapy Provides No Survival Benefit for Older Newswise (press release)
Study examines drug regimen for the treatment of non-small cell lung cancer Science Codex
The Oncology Report -PLoS Blogs (blog)
all 15 news articles »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: